Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Thursday, June 14, 2018
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
Neuropsychiatric symptoms such as agitation, aggression and psychosis are frequently found in patients with neurodegenerative disorders. These symptoms increase the already significant burden of neurodegenerative diseases and complicate diagnosis and disease management, yet effective diagnostics and treatments are lacking.
Towards the goal of reducing this burden, this symposium will review state-of-the-art methods in the diagnosis and behavioral and pharmaceutical management of neuropsychiatric symptoms across a spectrum of neurodegenerative diseases. Speakers will address the challenges of defining neuropsychiatric symptoms in the context of neurodegenerative diseases, present findings regarding emerging diagnostic biomarkers and novel therapies, and discuss current estimates of associated societal and economic costs. A closing panel discussion will identify strategies to reduce these costs for patients, caregivers, and society.